Andrew Atz to Disease-Free Survival
This is a "connection" page, showing publications Andrew Atz has written about Disease-Free Survival.
Connection Strength
0.199
-
Survival data and predictors of functional outcome an average of 15?years after the Fontan procedure: the pediatric heart network Fontan cohort. Congenit Heart Dis. 2015 Jan-Feb; 10(1):E30-42.
Score: 0.109
-
Transplant-Free Survival and Interventions at 6 Years in the SVR Trial. Circulation. 2018 05 22; 137(21):2246-2253.
Score: 0.035
-
Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27; 371(22):2061-71.
Score: 0.028
-
Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation. 2014 May 20; 129(20):2013-20.
Score: 0.027